GF Fund Management’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.77K	Hold	1,218	–	–	﹤0.01%	649
2025 Q1	$1.68K	Buy	1,218 +187	+18%	+$258	﹤0.01%	654
2024 Q4	$3.13K	Buy	+1,031	New	+$3.13K	﹤0.01%	629